Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

244 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue?
Laleman W, Trebicka J, Verbeke L. Laleman W, et al. Among authors: trebicka j. Hepatology. 2016 Nov;64(5):1792-1794. doi: 10.1002/hep.28771. Epub 2016 Sep 30. Hepatology. 2016. PMID: 27531824 No abstract available.
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
Heller J, Trebicka J, Shiozawa T, Schepke M, Neef M, Hennenberg M, Sauerbruch T. Heller J, et al. Among authors: trebicka j. Liver Int. 2005 Jun;25(3):657-66. doi: 10.1111/j.1478-3231.2005.01053.x. Liver Int. 2005. PMID: 15910503
Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, Sauerbruch T, Heller J. Zhou Q, et al. Among authors: trebicka j. Gut. 2006 Sep;55(9):1296-305. doi: 10.1136/gut.2005.081059. Epub 2006 Feb 21. Gut. 2006. PMID: 16492715 Free PMC article.
Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M, Jakobs KH, Sauerbruch T, Heller J. Hennenberg M, et al. Among authors: trebicka j. Gastroenterology. 2006 Mar;130(3):838-54. doi: 10.1053/j.gastro.2005.11.029. Gastroenterology. 2006. PMID: 16530523
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J. Trebicka J, et al. Hepatology. 2007 Jul;46(1):242-53. doi: 10.1002/hep.21673. Hepatology. 2007. PMID: 17596891
Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
Trebicka J, Leifeld L, Hennenberg M, Biecker E, Eckhardt A, Fischer N, Pröbsting AS, Clemens C, Lammert F, Sauerbruch T, Heller J. Trebicka J, et al. Hepatology. 2008 Apr;47(4):1264-76. doi: 10.1002/hep.22170. Hepatology. 2008. PMID: 18318439
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.
Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T. Hennenberg M, et al. Among authors: trebicka j. Br J Pharmacol. 2009 May;157(2):258-70. doi: 10.1111/j.1476-5381.2009.00158.x. Epub 2009 Mar 26. Br J Pharmacol. 2009. PMID: 19338580 Free PMC article.
Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexus.
Hennenberg M, Trebicka J, Fischer HP, Heller J, Sauerbruch T. Hennenberg M, et al. Among authors: trebicka j. Microvasc Res. 2009 Sep;78(2):235-40. doi: 10.1016/j.mvr.2009.05.002. Epub 2009 May 13. Microvasc Res. 2009. PMID: 19442672
Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis.
Hennenberg M, Trebicka J, Kohistani AZ, Heller J, Sauerbruch T. Hennenberg M, et al. Among authors: trebicka j. Eur J Clin Invest. 2009 Oct;39(10):906-13. doi: 10.1111/j.1365-2362.2009.02181.x. Epub 2009 Jun 12. Eur J Clin Invest. 2009. PMID: 19522833
244 results
Jump to page
Feedback